Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
Summit History
20th Bioshares Biotech Summit
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Acrux
Actinogen (ACW)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Cynata Therapeutics
Dimerix (DXB)
Imugene (IMU)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
July 14th, 2026
Imugene to Raise $11 Million in Placement and Looks for Licensing Deal
Read More
July 14th, 2026
Cogstate - Record Sales for FY2026
Read More
July 14th, 2026
Syntara's Compound Records Some Activity in Prodromal Parkinson's Disease
Read More
July 14th, 2026
Neuren - CHMP Reverses View on DAYBU in Europe
Read More
June 22nd, 2026
Steady Adoption by Big Pharma Continues for Clever Culture Systems
Read More
June 22nd, 2026
Double Negative for Cynata Therapeutics
Read More
June 22nd, 2026
Dimerix Secures Fifth International Licensing Deal
Read More
June 5th, 2026
Acrux Licenses HRT Product in Australia and Seeks to Bring First Women's Testosterone Therapy to Market in US
Read More
June 5th, 2026
Two Major Trial Readouts for Cynata Therapeutics this Month
Read More
June 5th, 2026
Aroa Biosurgery - "Breakout Year"
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
